Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases

• Md Yuzaiful Md Yusof,
• Md Yuzaiful Md Yusof,
• Stefano Alivernini,
• Stefano Alivernini,
• Katerina Chatzidionysiou

Affiliations

Md Yuzaiful Md Yusof

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

Md Yuzaiful Md Yusof

National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, United Kingdom

Stefano Alivernini

Immunology Core Facility, Gemelli Science Technological Park, GSTeP, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy

Stefano Alivernini

Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)—Università Cattolica del Sacro Cuore, Rome, Italy

Katerina Chatzidionysiou

Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden